Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cesare Gridelli

Showing results (91-100 of 357) with videos related to

Pageof 36
Sort By:
Expert Review of Anticancer Therapy|December 1, 2017
Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitorsAssunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Frontiers in Immunology|August 8, 2020
Targeting Immunometabolism Mediated by CD73 Pathway in <i>EGFR</i>-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune ResistanceAnna Passarelli, Michele Aieta, Alessandro Sgambato, et al.
Tumori|October 7, 2005
Synchronous bilateral retinal metastases from lung adenocarcinomaAntonio Rossi, Andrea Manto, Paolo Maione, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 24, 2007
Adjuvant chemotherapy in elderly patients with non-small-cell lung cancerCesare Gridelli, Paolo Maione, Daniela Comunale, et al.
Clinical Lung Cancer|January 29, 2011
Treatment, rationale, and study design of TALISMAN study: a randomized phase II open-label study of second-line erlotinib versus intermittent erlotinib dosing with docetaxel in the treatment of former-smoker men affected by recurrent squamous non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paola Venturino, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
Identifying an optimum treatment strategy for patients with advanced non-small cell lung cancerFrancesco Grossi, Cesare Gridelli, Marianna Aita, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?Paolo Maione, Antonio Rossi, Massimo Di Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Outcome of patients with a performance status of 2 in the Multicenter Italian Lung Cancer in the Elderly Study (MILES)Francesco Perrone, Massimo Di Maio, Ciro Gallo, et al.
Expert Review of Anticancer Therapy|June 13, 2019
The role of combination chemo-immunotherapy in advanced non-small cell lung cancerDanilo Rocco, Luigi Della Gravara, Ciro Battiloro, et al.
The Oncologist|June 2, 2009
Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancerCesare Gridelli, Paolo Maione, Marianna Luciana Ferrara, et al.
Pageof 36

Showing results (91-100 of 357) with videos related to

Sort By:
Pageof 36
Expert Review of Anticancer Therapy|December 1, 2017
Targeted therapies in non-small cell lung cancer: a focus on ALK/ROS1 tyrosine kinase inhibitorsAssunta Sgambato, Francesca Casaluce, Paolo Maione, et al.
Frontiers in Immunology|August 8, 2020
Targeting Immunometabolism Mediated by CD73 Pathway in <i>EGFR</i>-Mutated Non-small Cell Lung Cancer: A New Hope for Overcoming Immune ResistanceAnna Passarelli, Michele Aieta, Alessandro Sgambato, et al.
Tumori|October 7, 2005
Synchronous bilateral retinal metastases from lung adenocarcinomaAntonio Rossi, Andrea Manto, Paolo Maione, et al.
Cancer Control : Journal of the Moffitt Cancer Center|January 24, 2007
Adjuvant chemotherapy in elderly patients with non-small-cell lung cancerCesare Gridelli, Paolo Maione, Daniela Comunale, et al.
Clinical Lung Cancer|January 29, 2011
Treatment, rationale, and study design of TALISMAN study: a randomized phase II open-label study of second-line erlotinib versus intermittent erlotinib dosing with docetaxel in the treatment of former-smoker men affected by recurrent squamous non-small-cell lung cancerCesare Gridelli, Antonio Rossi, Paola Venturino, et al.
Critical Reviews in Oncology/Hematology|February 5, 2008
Identifying an optimum treatment strategy for patients with advanced non-small cell lung cancerFrancesco Grossi, Cesare Gridelli, Marianna Aita, et al.
Lung Cancer (Amsterdam, Netherlands)|March 31, 2009
Tumor-related leucocytosis and chemotherapy-induced neutropenia: linked or independent prognostic factors for advanced non-small cell lung cancer?Paolo Maione, Antonio Rossi, Massimo Di Maio, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 22, 2004
Outcome of patients with a performance status of 2 in the Multicenter Italian Lung Cancer in the Elderly Study (MILES)Francesco Perrone, Massimo Di Maio, Ciro Gallo, et al.
Expert Review of Anticancer Therapy|June 13, 2019
The role of combination chemo-immunotherapy in advanced non-small cell lung cancerDanilo Rocco, Luigi Della Gravara, Ciro Battiloro, et al.
The Oncologist|June 2, 2009
Cetuximab and other anti-epidermal growth factor receptor monoclonal antibodies in the treatment of non-small cell lung cancerCesare Gridelli, Paolo Maione, Marianna Luciana Ferrara, et al.
Pageof 36